Abstract:Background: Polypharmacy has become a major and growing public health issue, with significant implications for health outcomes and expenditure on healthcare resources. In this study, a risk prediction model of polypharmacy represented by a nomogram for community-dwelling elderly patients based on the Chinese population was constructed. Methods: A cross-sectional study was conducted in Shanghai, China. The variables data affecting polypharmacy were fetched from the information system database of health government departments in Shanghai. The Least Absolute Shrinkage Selection Operator (LASSO) regression analysis was used to select the predictor variables, and multivariate logistic regression was used to establish the prediction model. A visual tool of the nomogram was established for predicting the risk of polypharmacy in the elderly population. In addition, the receiver operating characteristic (ROC) curve, calibration curve, and decision curve analysis (DCA) were used to estimate the performance of the model. Results: A total of 80,012 elderly patients were included in this study. Eight variables, containing age, residential area, preferred medical institutions, number of visits to tertiary hospitals, number of visits to secondary hospitals, number of visits to community health centers, number of diagnoses, and main types of disease, were included in the risk prediction model of nomogram. The area under the curve (AUC) of the nomogram was 0.782 in both sets, demonstrating that the model has a good discriminant ability. The calibration chart shows that the prediction model fits well with the validation set. DCA results displayed that the threshold probabilities of the two sets in the prediction model reached up to 90%, implying that the model had a preferable application value. Conclusion: This study explored the risk factors for polypharmacy among the elderly in Shanghai, China, and applied the nomogram to establish a predictive model via eight variables, which provided an effective tool for early screening and timely prevention of polypharmacy. Family physicians or pharmacists could scientifically use the tool to closely observe community-dwelling elderly patients, decreasing the adverse health effects caused by medication for the elderly.

Common use of antipsychotic polypharmacy in older Asian patients with schizophrenia (2001-2009).

Antipsychotic polypharmacy in inpatients with schizophrenia in Asia (2001-2009).

Antipsychotic polypharmacy in schizophrenia patients in China and its association with treatment satisfaction and quality of life: findings of the third national survey on use of psychotropic medications in China.

Common use of high doses of antipsychotic medications in older Asian patients with schizophrenia (2001-2009).

Use of first- and second-generation antipsychotic medications in older patients with schizophrenia in Asia (2001-2009).

Common Use of Anticholinergic Medications in Older Patients with Schizophrenia: Findings of the Research on Asian Psychotropic Prescription Pattern (REAP) Study, 2001–2009

Prescribing Patterns of Low Doses of Antipsychotic Medications in Older Asian Patients with Schizophrenia, 2001–2009

Antipsychotic Treatment in Older Schizophrenia Patients with Extrapyramidal Side Effects in Asia (2001 - 2009).

Use of Clozapine in Older Asian Patients with Schizophrenia Between 2001 and 2009

Use of Anticholinergic Drugs in Patients with Schizophrenia in Asia from 2001 to 2009

Prescribing antipsychotic drugs for inpatients with schizophrenia in Asia: Comparison of REAP-2001 and REAP-2004 studies: Prescribing antipsychotics in REAP study

Risk prediction model of polypharmacy for community-dwelling elderly patients: An assessment tool for early detection

Concurrent Antipsychotic Use in Older Adults Treated with Antidepressants in Asia

Trends of polypharmacy among older people in Asia, Australia and the United Kingdom: a multinational population-based study

Trends of Polypharmacy and Prescription Patterns of Antidepressants in Asia

Antipsychotic drug prescription for schizophrenia in East Asia: rationale for change.

Depot Antipsychotic Use in Schizophrenia: an East Asian Perspective

Adjunctive Antidepressant Prescriptions for Hospitalized Patients with Schizophrenia in Asia (20012009)

Frequency and correlates of antipsychotic polypharmacy among patients with schizophrenia in Denmark: A nation-wide pharmacoepidemiological study

High Dose Antipsychotic Use in Schizophrenia: Findings of the REAP (research on East Asia Psychotropic Prescriptions) Study

Patterns of Antipsychotic Prescriptions in Patients with Schizophrenia in China: A National Survey